3-8769967-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000472766.1(CAV3):​n.156-7510G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.111 in 152,126 control chromosomes in the GnomAD database, including 1,250 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1250 hom., cov: 32)

Consequence

CAV3
ENST00000472766.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.824

Publications

4 publications found
Variant links:
Genes affected
CAV3 (HGNC:1529): (caveolin 3) This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites. [provided by RefSeq, Jul 2008]
CAV3 Gene-Disease associations (from GenCC):
  • caveolinopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant limb-girdle muscular dystrophy type 1C
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • long QT syndrome 9
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rippling muscle disease 2
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • distal myopathy, Tateyama type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • inherited rippling muscle disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Brugada syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
  • hypertrophic cardiomyopathy 1
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia
  • long QT syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.211 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAV3ENST00000472766.1 linkn.156-7510G>T intron_variant Intron 1 of 2 2

Frequencies

GnomAD3 genomes
AF:
0.111
AC:
16930
AN:
152008
Hom.:
1251
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.216
Gnomad AMI
AF:
0.0230
Gnomad AMR
AF:
0.0861
Gnomad ASJ
AF:
0.126
Gnomad EAS
AF:
0.113
Gnomad SAS
AF:
0.0693
Gnomad FIN
AF:
0.0307
Gnomad MID
AF:
0.133
Gnomad NFE
AF:
0.0692
Gnomad OTH
AF:
0.120
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.111
AC:
16940
AN:
152126
Hom.:
1250
Cov.:
32
AF XY:
0.108
AC XY:
8041
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.215
AC:
8921
AN:
41454
American (AMR)
AF:
0.0858
AC:
1312
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.126
AC:
438
AN:
3472
East Asian (EAS)
AF:
0.114
AC:
588
AN:
5180
South Asian (SAS)
AF:
0.0698
AC:
336
AN:
4814
European-Finnish (FIN)
AF:
0.0307
AC:
325
AN:
10586
Middle Eastern (MID)
AF:
0.139
AC:
41
AN:
294
European-Non Finnish (NFE)
AF:
0.0691
AC:
4703
AN:
68014
Other (OTH)
AF:
0.121
AC:
255
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
753
1506
2260
3013
3766
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0828
Hom.:
1236
Bravo
AF:
0.119
Asia WGS
AF:
0.0990
AC:
343
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
4.7
DANN
Benign
0.46
PhyloP100
0.82
PromoterAI
-0.018
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1465386; hg19: chr3-8811653; API